National Institutes of Health (NIH) — 2018 Investments
254 investments dated 2018 · page 1 of 2 · listed companies and verified rows first · show all
BillionToOne is a precision diagnostics company that uses molecular counting technology to develop non-invasive prenatal screening and liquid biopsy tests for early disease detection.
BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US
Oguzhan Atay, PhD(Co-Founder, CEO, and Board Chair)David Tsao, PhD(Co-Founder, CTO, and Board Member)Oguzhan Atay(Founder)inDavid Tsao(Founder/CTO)inSukrit Silas(Cofounder)
Cartesian Therapeutics develops mRNA-based cell therapies for autoimmune diseases.
BiotechHealthtechWatertown, US
Metin Kurtoglu(Executive Officer)Chris Jewell(Executive Officer)Carsten Brunn(Executive Officer, Director)Emily English(Executive Officer)Blaine Davis(Executive Officer)Stephen Smolinksi(Executive Officer)
Senti Bio develops cell and gene therapies for cancer and difficult-to-treat diseases using synthetic biology and engineered Gene Circuits to enhance precision, control, and selectivity in targeting tumor cells.
BiotechDeep TechMedical DevicesSouth San Francisco, US
Tim Lu(Co-Founder and Chief Executive Officer)James Collins(Director)Kanya Rajangam(President, Head of Research & Development and Chief Medical Officer)Yvonne Li(Executive Officer)Philip Lee(Executive Officer)
BoardDonald Tang(Director)
Akoya (part of Quanterix) develops biomarker detection platforms combining liquid Simoa immunoassays for blood and CSF with spatial tissue proteomics, providing matched biomarker insights across matrices.
BiotechHealthtechMedical DevicesBillerica, US
Garry Nolan(Director)Thomas Raffin(Director)Matthew Winkler(Director)Brian McKelligon(Executive Officer)
BoardRob Hart(Executive Officer)Robert Shepler(Director)
Alleviant Medical develops an investigational minimally invasive medical device using interatrial shunt therapy to treat heart failure patients, currently in FDA-approved clinical trials (ALLAY-HF and ALLAY-HFrEF).
BiotechHealthtechMedical DevicesAustin, US
Adam Berman(Executive Officer, Director)Jacob Kriegel(Executive Officer, Director)Avni Patel(Executive Officer, Director)Christopher Alex Arevalos(Executive Officer, Director)Albertien Greijdanus(Executive Officer, Director)
BoardGeoff Pardo(Director)
Altis Biosystems builds RepliGut®, human intestinal tissue models grown from human intestinal stem cells that provide human-relevant preclinical data for drug absorption, metabolism, toxicity, and disease modeling.
BiotechDeep TechHealthtechMedical DevicesDurham, US
Christopher Sims(Executive Officer)Jimmy Smedley(Executive Officer)Samuel Franklin(Director)Joseph McMahon(Director)Michael Biron(Executive Officer, Director)Swetha Peddibhotla(Senior Scientist)
HealthtechChantilly, US
Olivia Walch(Executive Officer, Director)Michael Masterson(Director)Daniel Forger(Executive Officer, Director)
Axcend builds compact, portable HPLC (high-performance liquid chromatography) instruments, including the Focus LC line with automated sampling, real-time reaction monitoring, and multi-wavelength UV detection.
BiotechDeep TechHardwareSalt Lake City, US
BRANDON D FUGAL(MANAGER)CHRISTOPHER M LEE(MANAGER)MILTON L LEE(MANAGER)GLEN D MELLA(CHIEF EXECUTIVE OFFICER)
Behaivior is a digital health company using AI, behavioral health technology, and wearables to improve mental health recovery and crisis prevention for individuals at risk of addiction and mental health crises.
AI & Machine LearningCybersecurityDigital HealthHealthtechMental HealthPittsburgh, US
Calder Biosciences is a molecular engineering company developing novel vaccines against RSV, influenza, and other viral infections using platform technology for vaccine design and manufacturing.
BiotechMedical DevicesNYC, US
care.coach provides 24/7 companionship and health monitoring for seniors through an AI-powered tablet with a pet avatar interface, supporting medication compliance, fall prevention, and family connection.
Digital HealthHealthtechWellness & Fitness
CaroGen develops immunotherapies for cancer treatment, including the CARG-2020 platform for ovarian and colorectal cancer, and is partnering with the NIH on a universal influenza vaccine.
BiotechHealthtechFarmington, US
Centerline Biomedical develops IOPS®, a 510(k)-cleared endovascular navigation technology that provides real-time 3D image guidance for physicians performing catheterization and other endovascular procedures.
BiotechDeep TechHealthtechMedical DevicesCleveland, US
Gulam Khan(Executive Officer, Director)Indrani Egleston(Executive Officer)Vikash Goel(Executive Officer)Vinod K. Goel(Executive Officer)Akhil Saklecha(Director)Phil Rackliffe(Executive Officer, Director)
Click Therapeutics develops software-based prescription medical treatments for patients with unmet medical needs, combining neuroscience with digital technology to create a new treatment modality.
Digital HealthHealthtechMedical DevicesNew York, US
David B. Klein(Founder and CEO)Randall Stanicky(Executive Officer)Nicholas Schork(Director)Victor Gao(Director)Emile Westergaard(Director)
BoardAlex Zisson(Director)
Consensus Networks offers a digital asset management dashboard that lets users aggregate and manage cryptocurrencies and NFTs across multiple blockchain protocols, including Ethereum.
Crypto & Web3Data & Infrastructure
Eclipse Orthopaedics is developing the Radioscopic Targeting Attachment (RTA), a freehand targeting and drilling device to help surgeons perform distal locking during intramedullary nail fixation of leg and hip fractures with less operative time and reduced radiation exposure.
Advanced ManufacturingHardwareHealthtechMedical DevicesWarsaw, US
Barry W. Rich(Executive Officer, Director)David B. Rich(Executive Officer, Director, Promoter)
Eko develops FDA-cleared digital stethoscopes and AI-powered software that enables healthcare professionals to detect and diagnose cardiovascular disease with greater accuracy.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Connor Landgraf(Co-Founder and CEO)Tyler CrouchJason Bellet(Co-Founder and Chief Business Officer)
Forcyte Biotechnologies develops drug screening tools that measure cell contractility to identify therapeutic candidates for diseases driven by abnormal cellular force generation, such as asthma, fibrosis, and hypertension.
HealthtechMedical DevicesLos Angeles, US
Ivan Pushkarsky(Founder)inDino Di Carlo(Founder)in
BiotechResearch Triangle Park, US
Amanda Elam(Executive Officer, Director)Edward Breitschwerdt(Director)B. Jefferson Clark(Executive Officer, Director)Nicole Bell(Executive Officer, Director)
BoardRichard West(Director)
GlycoSurf produces high-purity (>95%) bio-inspired glycolipid and rhamnolipid surfactants using a green chemistry synthetic process, with sugar head-groups including glucose, galactose, and xylose and customizable chain lengths.
BiotechCleantechNew Materials
GlyTR Therapeutics is an early-stage biotech company developing a new class of anti-cancer immunotherapeutic molecules and CAR-T cells.
BiotechHealthtech
BiotechEast Lansing, US
Steven Bloembergen, PhD(Executive Officer, Director)Steven Bloembergen(Executive Officer, Director)Kenneth Pienta(Director)Frank van Luttikhuizen(Director)
BoardMichael Snyder(Director)Joerg Lahann, Ph.D.(Director)
HabitAware provides a wearable bracelet (Keen2) that uses vibration alerts to help users build awareness of and control body-focused repetitive behaviors like hair pulling, skin picking, and nail biting.
HardwareHealthtechMental HealthSaint Louis Park, US
Aneela Idnani(Executive Officer, Promoter)Kirk Klobe(Executive Officer, Director, Promoter)Sameer Kumar(Executive Officer, Director, Promoter)John Pritchard(Executive Officer, Promoter)
hc1 offers hc1 IQ, an AI-based platform that turns laboratory and diagnostic data into clinical, operational, supply chain, and market-growth intelligence for health systems and providers.
AI & Machine LearningDigital HealthHealthtech
HealthtechMadison, US
Thomas Rockwell Mackie(Director)Roger Chylla(Executive Officer, Director)Hao Wang(Executive Officer)Praveen Sinha(Executive Officer, Director)Scott Button(Director)Arvind Subramanian(Executive Officer, Director)
i3 develops intravascular imaging technology that combines ultrasound (IVUS) with near-infrared fluorescence (NIRF) for physicians performing percutaneous coronary intervention procedures.
Medical Devices
Immusoft develops novel therapeutic treatments by programming B cells to produce therapeutic proteins for patients with rare and other diseases with significant unmet medical need.
BiotechSeattle, US
Matthew Scholz(Founder)Mark Ahn, Ph.D.(Director)Sean Ainsworth(Chief Executive Officer)
Immvention Therapeutics develops first-in-class BACH1 inhibitors intended as an oral therapy for patients with sickle cell disease and other conditions.
BiotechDigital Health
Imtherapeutics develops oral therapies for Type 1 diabetes patients with specific genetic markers.
Biotech
Inimmune is a clinical-stage biotech company that discovers and develops immunotherapies based on innate immune modulation, including Toll-like receptor agonists, to treat inflammatory conditions such as allergy, cancer, and autoimmune disease.
BiotechHealthtech
BiotechPortola Valley, US
Lena Wu(Executive Officer, Director)Erik Gentalen(Director)Michael Rubin(Director)
BoardJenny Rooke(Director)
Kinto provides personal care coaching to family caregivers looking after a loved one with dementia, pairing them with a designated Care Coach and offering a curriculum with personalized action plans.
Digital HealthHealthtechWellness & Fitness
BiotechBoston, US
Carlos Castro Gonzalez(Executive Officer, Director)Ian Butterworth(Executive Officer, Director)Paul Hartung(Director)
BoardAmy Salzhauer(Director)
Materna Medical develops medical devices for women's pelvic health, including the FDA-cleared Milli vaginal dilator for treating vaginismus and painful intercourse, and the investigational Ellora System for labor support.
FemTechHealthtechMedical DevicesMountain View, US
Tracy MacNeal(Executive Officer, Director)Peter Wyles(Director)Arthur Reidel(Director)Jim Bochnowski(Director)Patrick Jamp(Director)
BoardAriella Golomb(Director)
MDI Therapeutics is a pharmaceutical company developing small molecule therapies for fibrosis and fibroproliferative diseases, including MDI-2517, an inhibitor of plasminogen activator inhibitor 1 (PAI-1) currently in a Phase 1 clinical study.
BiotechHealthtechNovi, US
Daniel Lawrence, Ph.D.(Executive Officer, Director)Duane Day(Executive Officer, Director)Stephen Benoit(Executive Officer, Director)
BiotechCambridge, US
Daniel Vannoni(Director)Raja Srinivas(Director)Madhavi Gavini(Executive Officer, Director)
NuShores develops a patented bone scaffold technology, marketed as NuCress, designed to promote healing of large segmental bone breaks over 2.5 cm.
BiotechHealthtechMedical DevicesLittle Rock, US
Sharon Ballard(Executive Officer, Director)Alex S. Biris(Executive Officer, Director)
HealthtechNew York, US
Rosina Samadani(Executive Officer, Director)Uzma Samadani(Director)Pratipatti Laxminarain(Director)
BoardJill Enos(Director)Kathryn Swintek(Director)
Oxalo Therapeutics develops therapeutics for rare renal diseases and the prevention of recurrent kidney stones, starting with primary hyperoxaluria, an orphan monogenic liver disease that causes excessive oxalate.
BiotechHealthtechChicago, US
Yang Zheng(Director)Hatim Hassan(Executive Officer, Director)
Pendar Technologies develops Raman spectroscopy instruments and autonomous chemistry systems for chemical analysis and discovery, including handheld devices for identifying threat materials and tools for real-time reaction kinetics, inspection, authentication, and process control.
Deep TechDefense TechHardware
PhaseBio is a company focused on developing treatments for cardiovascular disease, which is a leading cause of death in the United States.
BiotechHealthtechMedical DevicesMalvern, US
Joel Sussman(Executive Officer)James Barrett(Director)Michael Gutch(Director)Justin Klein(Director)Jonathan Mow(Executive Officer, Director)Asish K. Xavier(Director)
Plumb Pharmaceuticals is a drug delivery startup developing pain and addiction treatments, holding several drug delivery patents.
BiotechMedical DevicesMadison, US
Alex Vodenlich
RevBio develops TETRANITE, a synthetic, bioengineered regenerative bone adhesive that transitions from a putty to a cement-like scaffold to bond bone-to-bone and bone-to-metal in wet-field surgical settings.
BiotechMedical DevicesNew Materials
SafeTraces provides DNA-based verification technology used to assess indoor air quality, ventilation, and biosecurity while balancing energy efficiency.
BiotechCleantechHealthtechPleasanton, US
Ulrike Hodges(Director)Antonios Zografos(Executive Officer, Director)John Kraus(Director)Rob Veres(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.